Skip to content

Zymeworks ZYME Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Operating margin-140.4%-6.6pp-87.3%+92.3pp-52.5%+170pp-67.3%+152pp-133.8%+161pp
Net margin-126.3%-4.6pp-76.6%+84.2pp-47.2%+136pp-60%+119pp-121.7%+128pp
Returns
Return on equity-42%-12.2pp-26.7%+3.8pp-18.5%+10.3pp-19.9%+6.4pp-29.8%-2.2pp
Efficiency
Asset turnover0.2×0.0×0.3×+0.1×0.3×+0.2×0.3×+0.2×0.2×
Liquidity
Current ratio10.8×+6.1×5.9×+2.5×6.9×+2.8×7.7×+0.7×4.7×-2.2×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Per Share
Book value per share$2.19-49.3%$3.56-20.3%$4.22-12.3%$4.32-18.7%$4.32-24.8%
Valuation
Market capitalization$1.86B+125%$1.99B+96.9%$1.29B+45.8%$959.51M+82.8%$828.66M+52.6%
Price / sales22.9×+14.0×18.7×+5.5×9.6×-4.6×7.8×-0.6×8.9×-1.9×
Price / book11.4×+8.8×7.4×+4.4×+1.6×2.9×+1.6×2.6×+1.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Zymeworks's ratios come from?
Every ratio is computed from Zymeworks's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.